01-12-2001 | Original Article
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics
Published in: Cancer Chemotherapy and Pharmacology | Issue 6/2001
Login to get access